Infiniti Research Highlights Cyber Attack Risks Faced by the Medical Devices Industry and Methods to Counter Them

☞ | View the text of this post. Exclusively available to ASQ Members.

The growing incidence of ransomware attacks in the UK and Indonesia has aroused a concern for cyber-attacks on medical devices across the globe. New technology is being adopted by the manufacturers of medical devices which will help in better diagnosing of health conditions.

However, Infiniti Research notes that while digitalization has improved the overall performance of medical devices, at the same time it has exposed the industry to events like hacking, malware, and cyber-attacks.

Infiniti Research provided

Antibiotics Tied to Side Effects in Nearly 20% of Hospitalized Patients, Says Study

☞ | View the text of this post. Exclusively available to ASQ Members.

The data indicated 20% of patients (n=298) who were prescribed antibiotics had at least one adverse event, with the risk increasing by 3% for every 10 additional days of antibiotic use.

Researchers from The Johns Hopkins Hospital found that nearly 1 in 5 hospitalized adults developed an antibiotic-associated adverse drug event after receiving antibiotic therapy. Findings from their study are published in JAMA Internal Medicine .

The team evaluated electronic medical records of 1,488 adult patients admitted to

Online Retailer Amazon Buying Whole Foods

☞ | View the text of this post. Exclusively available to ASQ Members.

Online retail giant Amazon is making a bold expansion into physical stores with a $13.7 billion deal to buy Whole Foods, setting the stage for radical retail experiments that could revolutionize how people buy groceries and everything else.

Amazon will be able to use automation and data analysis to draw more customers to stores while helping Whole Foods cut costs—and perhaps prices—and better tailor its offerings to customers.

Amazon, meanwhile, will be able to use hundreds of

Gilead Submits Drug Application for Simplified HIV Treatment

☞ | View the text of this post. Exclusively available to ASQ Members.

Gilead Sciences has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single tablet regimen containing bictegravir (50 mg; BIC), a novel investigational integrase strand transfer inhibitor (INSTI), and emtricitabine/tenofovir alafenamide (200/25mg; F/TAF) for the treatment of HIV-1 infection in adults.

BIC/F/TAF has demonstrated high rates of virologic suppression and no treatment-emergent resistance through 48 weeks in Phase 3 clinical trials among treatment-nave adult patients and among

Liquefied Gas Electrolytes Power New Lower-Temperature Battery

☞ | View the text of this post. Exclusively available to ASQ Members.

Scientists at the University of California, San Diego (UCSD) have developed new electrolytes capable of powering batteries at temperatures as low as minus 80 degrees Celsius.

The technology could help make lithium ion batteries safer and more efficient, as well as boost the range of electric vehicles during cold winter months. The new batteries could also power vehicles and instruments operating in extreme cold, like space rovers, satellites and high-altitude weather balloons.

The electrolytes are composed of

Supreme Cuisine Recalls Meat and Poultry Fat and Lard Products Due to Processing Deviation

☞ | View the text of this post. Exclusively available to ASQ Members.

Supreme Cuisine, a Montgomery City, Mo. establishment, is recalling approximately 325,000 pounds of meat and poultry fat and lard products due to a processing deviation, which may result in the potential growth and survival of bacterial pathogens in the products, the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) announced today.

The duck, beef and pork fat and lard items were produced and packaged from June 1, 2016 through May 8, 2017. The

New Malaria Drug Shows Positive Results

☞ | View the text of this post. Exclusively available to ASQ Members.

The plasmodium parasite GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) have announced positive results of the phase III global program to evaluate the efficacy and safety of tafenoquine in treating plasmodium vivax (P. vivax) malaria.

Tafenoquine is an investigational medicine which is being developed for the treatment and relapse prevention (radical cure) of plasmodium vivax (P. vivax) malaria, a form of the disease caused by one of several species of plasmodium parasites known to infect

New Research Overcomes Major Hurdle to Wireless Charging of Moving Electric Vehicles

☞ | View the text of this post. Exclusively available to ASQ Members.

Researchers with Stanford University have developed a way to wirelessly deliver electricity to moving objects, which could one day charge electric vehicles and personal devices like medical implants and cell phones.

If electric cars could recharge while driving down a highway, it would eliminate concerns about their range and lower their cost.

A paper, published this week in the journal Nature , addresses the technology hurdle by introducing the way that electricity is transmitted wirelessly to a moving

Dr. Reddy’s Recalls Acne Medication From U.S. Market

☞ | View the text of this post. Exclusively available to ASQ Members.

City-based pharma giant Dr. Reddy’s Laboratories (DRL) has voluntarily recalled 13,221 cartons of Zenatane capsules, which is used to treat severe cystic acne, from the U.S. market.

Citing the reason for the recall, the company said the drug failed “dissolution specifications out of specification results observed for low dissolution.” The drug was being manufactured by Cipla Limited’s unit at Kurkumbh for DRL. The recall falls under ‘Class II’, which is defined by the U.S. Food and

Swimming Robot to Probe Damage at Japan Nuclear Plant

☞ | View the text of this post. Exclusively available to ASQ Members.

A Japanese industrial group unveiled Thursday a robot designed for underwater probes of damage from meltdowns at the Fukushima Dai-Ichi nuclear plant after the March 2011 earthquake and tsunami.

Remote controlled robots are key to the decades-long decommissioning process for the plant. But super-high radiation and structural damage inside the reactors hampered earlier attempts to inspect areas close to the reactors’ cores.

The developers say they plan to send the new “mini manbo,” or “little sunfish,” probe